CP
GPCR icon

CenterBook Partners’s Structure Therapeutics GPCR Stock Holding History

CenterBook Partners’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.02M Buy
+21,237
New +$1.45M 0.06% 349

Other funds holding GPCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

CenterBook Partners's GPCR Position: Q1 2026 in Review

CenterBook Partners opened a new position in Structure Therapeutics (GPCR) in Q1 2026: 21,237 shares worth $1.02M. The stake represents 0.06% of the portfolio and ranks #349 among its holdings.

196 funds tracked by Wall St. Rank hold GPCR as of Q1 2026.

  • CenterBook Partners held 21,237 shares of Structure Therapeutics worth $1.02M as of Q1 2026.
  • Structure Therapeutics was a new CenterBook Partners position in Q1 2026.
  • Structure Therapeutics made up 0.06% of CenterBook Partners's portfolio in Q1 2026, its #349 holding.
  • 196 funds tracked by Wall St. Rank held Structure Therapeutics as of Q1 2026.

Based on CenterBook Partners's 13F filing for Q1 2026, filed 5 May 2026.